ArticleJournal of cancer research and clinical oncology2017

Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.

Nils Winkelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.